DarioHealth Corp. (NASDAQ:DRIO) Sees Large Growth in Short Interest

DarioHealth Corp. (NASDAQ:DRIO) saw a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 1,800,000 shares, an increase of 11.1% from the August 15th total of 1,620,000 shares. Based on an average trading volume of 93,900 shares, the days-to-cover ratio is presently 19.2 days.

Hedge Funds Weigh In On DarioHealth

An institutional investor recently bought a new position in DarioHealth stock. Clarity Capital Partners LLC bought a new stake in shares of DarioHealth Corp. (NASDAQ:DRIO) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 170,426 shares of the company’s stock, valued at approximately $293,000. Clarity Capital Partners LLC owned approximately 0.63% of DarioHealth at the end of the most recent reporting period. Hedge funds and other institutional investors own 33.39% of the company’s stock.

DarioHealth Stock Performance

Shares of DRIO stock traded up $0.10 during trading hours on Wednesday, reaching $0.97. The stock had a trading volume of 21,152 shares, compared to its average volume of 118,270. DarioHealth has a twelve month low of $0.68 and a twelve month high of $3.49. The firm has a market capitalization of $29.02 million, a PE ratio of -0.58 and a beta of 1.46. The firm has a 50-day simple moving average of $1.00 and a 200-day simple moving average of $1.28. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.26 and a quick ratio of 1.96.

DarioHealth (NASDAQ:DRIO) last released its earnings results on Thursday, August 8th. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.51) by $0.43. DarioHealth had a negative net margin of 265.33% and a negative return on equity of 74.64%. The firm had revenue of $6.26 million for the quarter, compared to analysts’ expectations of $7.57 million. As a group, equities analysts forecast that DarioHealth will post -1.21 earnings per share for the current year.

DarioHealth Company Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.